Marshall Wace
ELV icon

Marshall Wace’s Elevance Health ELV Stock Holding History

Marshall Wace’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100
Closed -$32.3K – 3088
2025
Q3 		$32.3K Buy
+100
New +$31.1K ﹤0.01% 2757

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Marshall Wace's ELV Position: Q2 2026 in Review

Marshall Wace increased its Elevance Health (ELV) stake by 453% in Q2 2026, buying an estimated $6.38M and bringing the position to 21,016 shares worth $8.13M. The position accounts for 0.01% of the portfolio, ranked #1123.

Marshall Wace first reported a position in ELV in Q1 2014 and has held it in 34 quarters since. The position peaked at $251M in Q1 2023. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Marshall Wace held 21,016 shares of Elevance Health worth $8.13M as of Q2 2026.
  • Marshall Wace bought 17,216 Elevance Health shares in Q2 2026, an estimated $6.38M.
  • Elevance Health made up 0.01% of Marshall Wace's portfolio in Q2 2026, its #1123 holding.
  • Marshall Wace first reported a position in Elevance Health in Q1 2014 and has held it in 34 quarters since.
  • Marshall Wace's Elevance Health position peaked at $251M in Q1 2023.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.